Related Experiment Video
Updated: Apr 1, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Epstein-Barr Virus Lytic Cycle Reactivation
Jessica McKenzie1, Ayman El-Guindy2
1Department of Pediatrics, Division of Infectious Diseases, Yale University School of Medicine, New Haven, CT, 06520, USA.
Epstein-Barr virus (EBV) lytic infection, though usually latent, plays a role in diseases. Understanding its molecular regulation is key for potential therapeutic strategies targeting viral progeny production.
Area of Science:
- Virology
- Molecular Biology
- Immunology
Background:
- Epstein-Barr virus (EBV) establishes both latent and lytic infection cycles.
- Lytic infection, characterized by viral replication and progeny production, is observed in healthy individuals and associated with certain diseases.
- The lytic cycle involves distinct stages: early gene expression, DNA replication, late gene expression, assembly, and egress.
Purpose of the Study:
- To summarize recent advancements in understanding the molecular mechanisms governing EBV lytic infection stages.
- To highlight the potential involvement of EBV lytic replication in disease pathogenesis.
- To review current therapeutic strategies aimed at inducing EBV lytic infection.
Main Methods:
- Review of recent scientific literature on Epstein-Barr virus lytic cycle.
- Analysis of molecular mechanisms regulating viral gene expression and replication.
- Examination of the link between EBV lytic activity and disease states.
Main Results:
- Detailed insights into the molecular regulation of EBV lytic stages, from early gene expression to viral egress.
- Evidence supporting the role of EBV lytic infection in the progression of specific pathological conditions.
- Overview of experimental approaches for inducing EBV lytic infection for therapeutic purposes.
Conclusions:
- Elucidating the molecular intricacies of EBV lytic infection is crucial for understanding its role in disease.
- Targeting EBV lytic replication presents a potential therapeutic avenue for EBV-associated conditions.
- Further research into EBV lytic cycle regulation may unlock novel treatment strategies.
Related Concept Videos
Viral Replication: Lysogenic Cycle
Viral Replication: Lytic Cycle
Lytic Cycle of Bacteriophages
Lysogenic Cycle of Bacteriophages
What are Viruses?
Cytomegalovirus Disease

